Most lately, it's been discovered that conolidine and the above mentioned derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to a big range of endogenous opioids. Contrary to most opioid receptors, this receptor acts as being a scavenger https://francisc887ssp7.blogsidea.com/profile